Antimicrobial Resistance News and Research

RSS

Naturally occurring compound possesses antibacterial activity against several microorganisms

University researchers have found a naturally occurring compound, known as hydroquinine, has bacterial killing activity against several microorganisms.

30 Aug 2022

Flipping the switch on retrons to combat antimicrobial resistance

In this interview, we speak to Dr. Jacob Bobonis about his new discovery regarding retrons and how they could be used to tackle antimicrobial resistance.

23 Aug 2022

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

Researchers developed an epidemiological model to simulate the co-circulation of SARS-CoV-2 and multidrug-resistant bacteria in healthcare facilities during the early phase of the COVID-19 pandemic.

18 Aug 2022

What drugs can be repurposed for monkeypox therapy?

In new research, researchers repurposed medications for the monkeypox virus in silico.

16 Aug 2022

One Medicine: A collaboration for the benefit of both humans and animals

One Medicine is described as many different things by many different people. The UK charity that drives One Medicine – Humanimal Trust – defines it as collaboration between vets, doctors and researchers so that all humans and animals benefit from equitable and sustainable medical progress, but not at the expense of an animal’s life.

12 Aug 2022

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

In an article, a mathematical model was used to explore how behavioral responses to the COVID-19 pandemic impact the anti-microbial resistance across communities.

11 Aug 2022

Next-generation sequencing system yields results comparable to traditional diagnostics

In the pursuit of accurate diagnoses for illnesses, doctors have traditionally used multiple methods — including culturing patient samples on a wide variety of media, reviewing countless medical records and analyzing clinical data using complex mathematical algorithms — to try to identify the bacterium, virus, fungus or other pathogen responsible for an infection.

10 Aug 2022

Researchers unravel the mechanism of teixobactin at the atomic level

Researchers explored the mechanisms underlying the bactericidal action of teixobactin at an atomic level.

8 Aug 2022

Early-life acquisition of antibiotic resistance in neonates from developing countries

Every year, almost 7 million potentially serious bacterial infections are estimated to occur in newborns, resulting in more than 550,000 annual neonatal deaths.

4 Aug 2022

New trial offers double the traditional course of antibiotics for patients with life threatening infections

Hospital patients who develop infections where 10% of sufferers die will be offered double the traditional course of antibiotics in a new trial.

1 Aug 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.

29 Jul 2022

Phage therapeutics can be used to fight multidrug-resistant pathogens

Scientists with the Texas A&M College of Agriculture and Life Sciences were among those providing the biochemical tools needed to help save a man's life through a unique emergency intervention in 2016.

27 Jul 2022

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on antimicrobial resistance.

18 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

The appropriate use of existing antibiotics and the development of new antibiotics targeting drug-resistant infections can slow the emergence, spread, and consequences of antimicrobial resistance (AMR); however, antibiotic research and development (R&D) has not responded to the urgent need for new antibiotics.

15 Jul 2022

Antimicrobial Resistance News and Research

Naturally occurring compound possesses antibacterial activity against several microorganisms

Flipping the switch on retrons to combat antimicrobial resistance

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

What drugs can be repurposed for monkeypox therapy?

One Medicine: A collaboration for the benefit of both humans and animals

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

Next-generation sequencing system yields results comparable to traditional diagnostics

Researchers unravel the mechanism of teixobactin at the atomic level

Early-life acquisition of antibiotic resistance in neonates from developing countries

New trial offers double the traditional course of antibiotics for patients with life threatening infections

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Phage therapeutics can be used to fight multidrug-resistant pathogens

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Researchers unravel mechanism that underlies failure of staph vaccine trials

New study discloses the reason behind the disappearance of highly infectious cholera variant

LSHTM and Reckitt launch new Forum to advance understanding of hygiene

Microbiology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News